Morgan Stanley is Awaiting Approvals and M&A on Mylan in the Wake of P/E Re-Rating

By: via Benzinga
In a report published Friday, Morgan Stanley analyst David Risinger reiterated an Equal-Weight rating on Mylan (NASDAQ: MYL ). In the report, Morgan Stanley noted, “MYL's multiple has re-rated; we see a balanced risk-reward ahead of NT binary events. MYL shares are currently trading at 16x our 2014E EPS of
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.